1810 related articles for article (PubMed ID: 11433224)
21. [Current considerations in syndrome of inappropriate secretion of antidiuretic hormone/syndrome of inappropriate antidiuresis].
Velasco Cano MV; Runkle de la Vega I
Endocrinol Nutr; 2010 May; 57 Suppl 2():22-9. PubMed ID: 21130959
[TBL] [Abstract][Full Text] [Related]
22. Increased uric acid clearance in the syndrome of inappropriate secretion of antidiuretic hormone.
Sonnenblick M; Rosin A
Isr J Med Sci; 1988 Jan; 24(1):20-3. PubMed ID: 3346144
[TBL] [Abstract][Full Text] [Related]
23. The hyponatremic patient: a systematic approach to laboratory diagnosis.
Milionis HJ; Liamis GL; Elisaf MS
CMAJ; 2002 Apr; 166(8):1056-62. PubMed ID: 12002984
[TBL] [Abstract][Full Text] [Related]
24. Effects of satavaptan, a selective vasopressin V(2) receptor antagonist, on ascites and serum sodium in cirrhosis with hyponatremia: a randomized trial.
Ginès P; Wong F; Watson H; Milutinovic S; del Arbol LR; Olteanu D;
Hepatology; 2008 Jul; 48(1):204-13. PubMed ID: 18508290
[TBL] [Abstract][Full Text] [Related]
25. [Valproate related syndrome of inappropriate secretion of antidiuretic hormone (SIADH)--a case report].
Ikeda K; Moriyasu H; Yasaka M; Oita J; Yamaguchi T
Rinsho Shinkeigaku; 1994 Sep; 34(9):911-3. PubMed ID: 7820967
[TBL] [Abstract][Full Text] [Related]
26. A novel vasopressin dual V1A/V2 receptor antagonist, conivaptan hydrochloride, improves hyponatremia in rats with syndrome of inappropriate secretion of antidiuretic hormone (SIADH).
Wada K; Matsukawa U; Fujimori A; Arai Y; Sudoh K; Sasamata M; Miyata K
Biol Pharm Bull; 2007 Jan; 30(1):91-5. PubMed ID: 17202666
[TBL] [Abstract][Full Text] [Related]
27. Management of the syndrome of inappropriate secretion of antidiuretic hormone.
Kinzie BJ
Clin Pharm; 1987 Aug; 6(8):625-33. PubMed ID: 3121240
[TBL] [Abstract][Full Text] [Related]
28. [Etiology, diagnostics and therapy of hyponatremias].
Laczi F
Orv Hetil; 2008 Jul; 149(29):1347-54. PubMed ID: 18617466
[TBL] [Abstract][Full Text] [Related]
29. Management of hyponatremia.
Goh KP
Am Fam Physician; 2004 May; 69(10):2387-94. PubMed ID: 15168958
[TBL] [Abstract][Full Text] [Related]
30. Hyponatremia in the syndrome of inappropriate secretion of antidiuretic hormone. Rapid correction with urea, sodium chloride, and water restriction therapy.
Decaux G; Unger J; Brimioulle S; Mockel J
JAMA; 1982 Jan 22-29; 247(4):471-4. PubMed ID: 7054549
[TBL] [Abstract][Full Text] [Related]
31. Vasopressin antagonists as aquaretic agents for the treatment of hyponatremia.
Palm C; Pistrosch F; Herbrig K; Gross P
Am J Med; 2006 Jul; 119(7 Suppl 1):S87-92. PubMed ID: 16843091
[TBL] [Abstract][Full Text] [Related]
32. Hyponatremia in cirrhosis: pathogenesis, clinical significance, and management.
Ginès P; Guevara M
Hepatology; 2008 Sep; 48(3):1002-10. PubMed ID: 18671303
[TBL] [Abstract][Full Text] [Related]
33. Therapeutic role of vasopressin receptor antagonism in patients with liver cirrhosis.
Ferguson JW; Therapondos G; Newby DE; Hayes PC
Clin Sci (Lond); 2003 Jul; 105(1):1-8. PubMed ID: 12639215
[TBL] [Abstract][Full Text] [Related]
34. Tolvaptan, an oral vasopressin antagonist, in the treatment of hyponatremia in cirrhosis.
Cárdenas A; Ginès P; Marotta P; Czerwiec F; Oyuang J; Guevara M; Afdhal NH
J Hepatol; 2012 Mar; 56(3):571-8. PubMed ID: 22027579
[TBL] [Abstract][Full Text] [Related]
35. Vasopressin antagonists: role in the management of hyponatremia.
Yeates KE; Morton AR
Am J Nephrol; 2006; 26(4):348-55. PubMed ID: 16837788
[TBL] [Abstract][Full Text] [Related]
36. Close association of urinary excretion of aquaporin-2 with appropriate and inappropriate arginine vasopressin-dependent antidiuresis in hyponatremia in elderly subjects.
Ishikawa Se ; Saito T; Fukagawa A; Higashiyama M; Nakamura T; Kusaka I; Nagasaka S; Honda K; Saito T
J Clin Endocrinol Metab; 2001 Apr; 86(4):1665-71. PubMed ID: 11297601
[TBL] [Abstract][Full Text] [Related]
37. Hyponatremia and hypouricemia: differentiation from SIADH.
Maesaka JK; Batuman V; Yudd M; Salem M; Sved AF; Venkatesan J
Clin Nephrol; 1990 Apr; 33(4):174-8. PubMed ID: 2350904
[TBL] [Abstract][Full Text] [Related]
38. Tolvaptan for the treatment of hyponatremia secondary to the syndrome of inappropriate antidiuretic hormone secretion.
Gargani L; Schmidt PH; Gheorghiade M
Expert Rev Cardiovasc Ther; 2011 Dec; 9(12):1505-13. PubMed ID: 22103869
[TBL] [Abstract][Full Text] [Related]
39. Acute aquaresis by the nonpeptide arginine vasopressin (AVP) antagonist OPC-31260 improves hyponatremia in patients with syndrome of inappropriate secretion of antidiuretic hormone (SIADH).
Saito T; Ishikawa S; Abe K; Kamoi K; Yamada K; Shimizu K; Saruta T; Yoshida S
J Clin Endocrinol Metab; 1997 Apr; 82(4):1054-7. PubMed ID: 9100572
[TBL] [Abstract][Full Text] [Related]
40. Hyponatremia and hypernatremia: disorders of water balance.
Agrawal V; Agarwal M; Joshi SR; Ghosh AK
J Assoc Physicians India; 2008 Dec; 56():956-64. PubMed ID: 19322975
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
